Litcius/Paper detail

Eriocalyxin B Inhibits Adipogenesis in 3T3-L1 Adipocytes by Cell Cycle Arrest

Rong‐Fang Mu, Yanfen Niu, Qian Wang, Huimin Zhou, Jing Hu, Wanying Qin, Wenyong Xiong

2020Natural Products and Bioprospecting27 citationsDOIOpen Access PDF

Abstract

Eriocalyxin B, an ent-Kaurene diterpenoid extracted from a traditional Chinese herb Isodon eriocalyx, has been shown to possess multifunctional activities such as anti-cancer and anti-inflammatory. However, the function and mechanism of the compound in adipocyte differentiation is still unknown. Here we reported that eriocalyxin B blunted adipogenesis remarkably by inhibiting the accumulation of lipid droplets, triglycerides and the expressions of adipogenesis-related factors, including C/EBPβ, C/EBPα, PPARγ, and FABP4. Moreover, we showed that the inhibition might be the consequence of cell cycle being arrested at the G2/M phase during the mitotic clonal expansion of adipocyte differentiation, most likely by suppressing mRNAs and proteins of CDK1, CDK2, Cyclin A and Cyclin B1. Overall, we conclude that eriocalyxin B is capable of inhibiting adipocyte differentiation at the early stage through downregulating the proteins involved in cell cycle progression.

Topics & Concepts

Adipogenesis3T3-L1AdipocyteLipid dropletCyclin-dependent kinase 1Cell cycleCell biologyCyclin ACyclin BCyclin B1CyclinChemistryMitosisCyclin-dependent kinase 2Function (biology)BiologyCellBiochemistryAdipose tissueAdipokines, Inflammation, and Metabolic DiseasesLipid metabolism and disordersCancer, Lipids, and Metabolism
Eriocalyxin B Inhibits Adipogenesis in 3T3-L1 Adipocytes by Cell Cycle Arrest | Litcius